Skip to main content

Advertisement

Log in

Trends in the clinical stage distribution of breast cancer in Osaka, Japan

  • Rapid Communication
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

We examined the proportion of screen-detected breast cancer cases and clinical stage distribution by age group among female breast cancer cases in Osaka, Japan using population-based cancer registry from the period 1980 to 2012. The proportion of local cases increased and that of regional cases decreased gradually during the study period. The proportion of distant cases leveled off. The proportion of in situ cases increased rapidly after 2003. This increase was noticeable for women aged 30–39, 40–49, 50–59, and 60–69 years. The proportion of in situ cases for women aged 40–49, 50–59, and 60–69 years reached 15.4, 11.3, and 9.9% in 2010–2012, respectively. Regarding screening status, the proportion of screen-detected cases before 1988 was under 3%. Between 1989 and 2003, it leveled off at around 5%. After 2003, the proportion increased noticeably, and reached 25.4%:34.0% in aged 40–49 years, 32.8% in aged 50–59 years, and 26.7% in aged 60–69 years. The increase in local cases and decrease in regional cases would be due to awareness of breast cancer, probably a result of developments in medical diagnostic technology. On the other hand, the steep increase of in situ cases might be due to screening. We need careful monitoring of the trends in breast cancer incidence by clinical stage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Abbreviations

OCR:

Osaka Cancer Registry

DCO:

Death certificate only

MHLW:

Ministry of Health, Labor and Welfare

References

  1. Vital, Health and Social Statistics Office, Director-General for Statistics and Information Policy, Ministry of Health, Labour and Welfare. Tokyo: Death Table 7; Vital Statistics 2015. http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei15/dl/11_h7.pdf. Accessed 20 Apr 2017 (in Japanese).

  2. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin N Am. 2004;42:793–806.

    Article  PubMed  Google Scholar 

  3. Smart CR, Hendrick RE, Rutledge JH 3rd, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer. 1995;75:1619–26.

    Article  CAS  PubMed  Google Scholar 

  4. Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, Japan. Tokyo: Cancer Screening Rate. [Cited 20 Apr 2017]. http://ganjoho.jp/reg_stat/statistics/dl/index.html#pref_screening. Accessed 20 Apr 2017 (in Japanese).

  5. Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer. 1989;59:954–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Chu KC, Kramer BS, Smart CR. Analysis of the role of cancer prevention and control measures in reducing cancer mortality. J Natl Cancer Inst. 1991;83:1636–43.

    Article  CAS  PubMed  Google Scholar 

  7. Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36:237–48.

    Article  PubMed  Google Scholar 

  8. Welch HG, Prorok PC, O’Malley AJ, Kramer BS. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med. 2016;375:1438–47.

    Article  PubMed  Google Scholar 

  9. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998–2005.

    Article  CAS  PubMed  Google Scholar 

  10. Toyoda Y, Tabuchi T, Nakayama T, Hojo S, Yoshioka S, Maeura Y. Past trends and future estimation of annual breast cancer incidence in Osaka, Japan. Asian Pac J Cancer Priv. 2016;17:2847–52.

    Google Scholar 

  11. Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 6, 1987 (in Japanese).

  12. Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 20, 1995 (in Japanese).

  13. Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 34, 2005 (in Japanese).

  14. Japanese Breast Cancer Society: the report of clinical statistical studies on registered breast cancer patients in Japan No. 43, 2016 (in Japanese).

  15. Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of monitoring and evaluation system. Br J Cancer. 1989;59:954–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Osaka Prefectural Department of Environment and Public Health, Osaka Medical Association, Osaka Medical Center for Cancer and Cardiovascular Disease: Annual Report of Osaka Cancer Registry No. 45, Cancer Incidence and Medical Care in Osaka in 1985, 1988 (in Japanese).

  17. Osaka Prefectural Department of Public Health and Welfare, Osaka Medical Association, Osaka Medical Center for Cancer and Cardiovascular Disease: Annual Report of Osaka Cancer Registry No. 80, Cancer Incidence and Medical Care in Osaka in 2011–2012 and the Survival in 2009, 2016 (in Japanese).

Download references

Acknowledgements

This work was supported by Grant-in-Aids from the Ministry of Education, Culture, Sports, Science, and Technology (Grant-in-Aid for Young Scientists B: No. 15K19256) without any role in the design, data selection, data analysis, or data interpretation of the study. We thank Dr. J. Mortimer for her English language editing. We are grateful to all the medical institutions in Osaka and the Osaka Medical Association for providing us with cancer incidence data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasuhiro Toyoda.

Ethics declarations

Conflict of interest

The authors have no conflicts of interests.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 406 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Toyoda, Y., Tabuchi, T., Nakayama, T. et al. Trends in the clinical stage distribution of breast cancer in Osaka, Japan. Breast Cancer 25, 250–256 (2018). https://doi.org/10.1007/s12282-017-0807-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-017-0807-7

Keywords

Navigation